Cover Image

It Is Time to Re‐Think the Limit of Quantitation

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Michael J. Fossler, Brian Smith
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Clinical Pharmacology in Drug Development
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Scientific Fraud: How Do We Ensure Sound Medical Literature?
by: Michael J. Fossler, et al.
Published: (2026)

Are We Overstudying Biosimilars? Re‐Centering Clinical Pharmacology in the Demonstration of Similarity
by: Amalia M. Issa
Published: (2026)

The Pathway to Proof‐of‐Concept for BNC210, a Negative Allosteric Modulator of the Alpha‐7 Nicotinic Acetylcholine Receptor (nAChR), for Treatment of Psychiatric Disease
by: Paul Rolan, et al.
Published: (2025)

Results from a Phase 1 Study Assessing the Pharmacokinetics of the Aldosterone Synthase Inhibitor Baxdrostat in Participants with Varying Degrees of Renal Function
by: Mason W. Freeman, et al.
Published: (2024)

Effects of High‐ and Low‐Fat Meals on the Bioavailability and Pharmacokinetics of Votoplam, a HTT Gene Splicing Modifier
by: Lucy Lee, et al.
Published: (2025)

Ethnic Bridging of Votoplam, a HTT Gene Splicing Modifier, Using Pharmacokinetic Comparison Between Caucasian and Japanese Subjects
by: Lucy Lee, et al.
Published: (2026)

Pharmacokinetics of Depemokimab Delivered by Safety Syringe Device or Autoinjector in Healthy Adults: A Phase 1, Single‐Dose Study
by: Stein Schalkwijk, et al.
Published: (2025)

Physiologically Based Pharmacokinetic Absorption Model for Pexidartinib to Evaluate the Impact of Meal Contents and Intake Timing on Drug Exposure
by: Shintaro Nakayama, et al.
Published: (2024)

Effects of Quinidine or Rifampin Co‐administration on the Single‐Dose Pharmacokinetics and Safety of Rilzabrutinib (PRN1008) in Healthy Participants
by: Christian Rask‐Madsen, et al.
Published: (2024)

A Drug–Drug Interaction Study of Mobocertinib and Midazolam, a Cytochrome P450 3A Substrate, in Patients With Advanced Non–Small Cell Lung Cancer
by: Michael J. Hanley, et al.
Published: (2025)

Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults
by: Caroline A. Lee, et al.
Published: (2024)

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies
by: Andrew C. Vendel, et al.
Published: (2026)

A Randomized, Cross‐Over Study Investigating the Comparability of Somatrogon‐ghla in 2 Different Drug Product Presentations
by: Allison Manners, et al.
Published: (2024)

A Phase 1C, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DM199 Administered Intravenously with a Polyvinyl Chloride Bag in Adult Healthy Subjects and Adults Recently Taking Angiotensin‐Converting Enzyme Inhibitors
by: Michael Giuffre, et al.
Published: (2025)

A Human Mass Balance and Metabolism Study of [ 14 C]‐Ubrogepant in Healthy Male Adults
by: Ramesh R. Boinpally, et al.
Published: (2026)

A Phase 1 Dose‐Escalation, Food Effect, and Drug–Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR‐1505, in Healthy Volunteers
by: Vipul K. Gupta, et al.
Published: (2026)

A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High‐Concentration, Long‐Acting Cabotegravir Formulation in Adults Without HIV
by: Kelong Han, et al.
Published: (2025)

Phase 1 Healthy Volunteer Study of AL01211, an Oral, Non‐brain Penetrant Glucosylceramide Synthase Inhibitor, to Treat Fabry Disease and Type 1 Gaucher Disease
by: Michael Babcock, et al.
Published: (2024)

Effects of Gastric Acid Suppression, Cytochrome P4503A Inhibition and Induction, and Food on the Pharmacokinetics of Tinlarebant in Healthy Adults
by: Thomas M. Polasek, et al.
Published: (2026)

Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results from a Randomized, Open‐Label, Parallel‐Group Study
by: Vincent Chow, et al.
Published: (2026)

A Phase 1 Study to Evaluate the Absorption, Metabolism, and Disposition of Dordaviprone in Healthy Adult Participants
by: Yohannes Teffera, et al.
Published: (2025)

Pharmacokinetic and Safety Comparison of Fixed‐Dose Combination of Cilostazol/Rosuvastatin (200 + 20 mg) Versus Concurrent Administration of the Separate Components in Healthy Adults
by: Jae Hoon Kim, et al.
Published: (2024)

Safety and Pharmacokinetics of a Combined Antioxidant Therapy against Myocardial Reperfusion Injury: A Phase 1 Randomized Clinical Trial in Healthy Humans
by: Abraham I.J. Gajardo Cortez, et al.
Published: (2024)

A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled, Single Ascending Dose Trial of AWZ1066S, an Anti‐Wolbachia Candidate Macrofilaricide
by: Graham Devereux, et al.
Published: (2024)

Dual Therapy Triumph: Yuquan Capsules and Metformin in Combating Type 2 Diabetes Mellitus Disorders
by: Lufan Zhang, et al.
Published: (2025)

Pharmacokinetics and bioequivalence of two N‐acetylcysteine tablets in healthy Chinese volunteers under fasting and fed conditions
by: Xianmiao Yin, et al.
Published: (2025)

A Phase 1, Randomized, Placebo‐Controlled, Multiple‐Dose, Double‐Blind Study to Evaluate and Compare the Pharmacokinetics and Safety of Rimegepant in Healthy Adult Japanese and Caucasian Individuals
by: Rajinder Bhardwaj, et al.
Published: (2025)

Evaluation of clinical cardiac safety of zilurgisertib, an activin receptor‐like kinase‐2 (ALK2) inhibitor, in healthy participants
by: Yan‐ou Yang, et al.
Published: (2025)

Disposition and Absolute Bioavailability of Orally Administered Orforglipron in Healthy Participants
by: Bridget L. Morse, et al.
Published: (2025)

Effect of Cytochrome P450 3A Inhibition and Induction by Itraconazole and Rifampin on Tazemetostat Pharmacokinetics in Patients With Advanced Malignancies
by: Yingxue Chen, et al.
Published: (2025)

Bioequivalence Study of 2 Formulations of Fluticasone Nasal Spray in Healthy Chinese Volunteers
by: Gang Chen, et al.
Published: (2025)

Safety, Tolerability, and Pharmacokinetics of Donanemab in Healthy Chinese Participants: A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled Study
by: Junyu Xu, et al.
Published: (2025)

Issue Information
Published: (2025)

Pharmacokinetics and Safety Evaluation of a New Generic Sitafloxacin: A Phase I Bioequivalence Study in Healthy Chinese Participants
by: Yongfang Lei, et al.
Published: (2025)

First‐in‐Human Study of Merotocin, a Short‐Acting Peptidic Oxytocin Receptor Agonist for Lactation Support
by: Yu Bagger, et al.
Published: (2025)

Phase 1 Mass Balance Study of Pizuglanstat: An Investigational Hematopoietic Prostaglandin D Synthase Inhibitor
by: Ryuzo Hanada, et al.
Published: (2025)

Strategies to Manage Dosing Deviations and Interruptions of Cabotegravir Long‐Acting Intramuscular Injections
by: Kelong Han, et al.
Published: (2025)

Issue Information
Published: (2025)

Issue Information
Published: (2025)

Combined Immediate‐Release and Extended‐Release Formulation of Sodium Valproate Provides Stable Plasma Levels for Inhibition of Histone Deacetylation
by: Nikhil Ahuja, et al.
Published: (2025)